Comparison of glomerular filtration rate estimates vs. 24-h creatinine clearance in HIV-positive patients

HIV Medicine

Volumn 10, Issue 4, 2009, Pages 219-228

  Ravasi, Giovanni ^a   Lauriola, M ^a   Tinelli, C ^a   Brandolini, M ^a   Uglietti, A ^a   Maserati, R ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Cockcroft Gault; Creatinine clearance; HIV infection; HIV associated nephropathy (HIVAN); Modification of diet in renal disease (MDRD); Renal function test

Indexed keywords

CD4 ANTIGEN; CREATININE; NITROGEN; UREA; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; FEMALE; GLOMERULUS FILTRATION RATE; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIORITY JOURNAL; SEX DIFFERENCE; UREA NITROGEN BLOOD LEVEL; ADOLESCENT; COMPLICATION; CROSS-SECTIONAL STUDY; KIDNEY FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PRACTICE GUIDELINE; PROCEDURES; URINE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD UREA NITROGEN; CREATININE; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HIV INFECTIONS; HUMANS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; YOUNG ADULT;

EID: 62749083924     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2008.00673.x     Document Type: Article

References (52)

1. Gupta SK, Eustace JA, Winston JA et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: Recommendations of the HIV Medicine Association of Infectious Diseases Society of America. Clin Infect Dis 2005; 40: 1559-1585.
2. Röling J, Schmid H, Fischereder M et al. HIV-associated renal disease and highly active antiretroviral therapy-induced nephropathy. Clin Infect Dis 2006; 42: 1488-1495.
3. Ross MJ, Klotman PE, Winston JA. HIV-associated nephropathy: Case study and review of literature. AIDS Pat Care STDS 2000; 14: 637-645.
4. Gupta SK, Mamlin BW, Johnson CS et al. Prevalence of proteinuria and the development of chronic kidney disease in HIV-infected patients. Clin Nephrol 2004; 61: 1-6.
5. Szczech LA, Gange SJ, Van der Horst C et al. Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int 2002; 61: 195-202.
6. Szczech LA, Hoover DR, Feldman JG et al. Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy. Clin Infect Dis 2004; 39: 1199-1206.
7. Gardner LI, Holmberg SD, Williamson JM et al. HIV Epidemiology Research Study Group. Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. J Acquir Immune Defic Syndr 2003; 32: 203-209.
8. Rao TK, Friedman EA, Nicastri AD. The types of renal disease in the acquired immunodeficiency syndrome. N Engl J Med 1987; 316: 1062-1068.
9. Cohen AH, Sun NC, Shapshak P et al. Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy. Mod Pathol 1989; 2: 125-128.
10. Winston JA, Klotman ME, Klotman PR. HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. Kidney Int 1999; 55: 1036-1040.
11. D'Agati V, Appel GB. HIV infection and the kidney. J Am Soc Nephrol 1997; 8: 138-152.
12. Kimmel PL, Barisoni L, Kopp JB. Pathogenesis and treatment of HIV-associated renal diseases: Lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations. Ann Intern Med 2003; 139: 214-227.
13. Del Arco A, Martinez MA, Pena JM et al. Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus infection: demonstration of p24 antigen in endothelial cells. Clin Infect Dis 1993; 17: 360-363.
14. Krawczyk CS, Holmberg SD, Moorman AC et al. HIV Outpatient Study Group. Factors associated with chronic renal failure in HIV-infected ambulatory patients. AIDS 2004; 18: 2171-2178.
15. Cheng JT, Anderson HL Jr, Markowitz GS. Hepatitis C virus-associated glomerular disease in patients with human immunodeficiency virus coinfection. J Am Soc Nephrol 1999; 10: 1566-1574.
16. Szczech LA, Gupta SK, Habash R et al. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 2004; 66: 1145-1152.
17. Lucas GM, Eustace JA, Sozio S et al. Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: A 12-year cohort study. AIDS 2004; 18: 541-546.
18. Ahuja TS, Borucki M, Grady J. Highly active antiretroviral therapy improves survival of HIV-infected hemodialysis patients. Am J Kidney Dis 2000; 36: 574-580.
19. Gagnon RF, Tecimer SN, Watters AK et al. Prospective study of urinalysis abnormalities in HIV-positive individuals treated with indinavir. Am J Kidney Dis 2000; 36: 507-515.
20. Mocroft A, Kirk O, Gatell J et al. Chronic renal failure among HIV-1-infected patients. AIDS 2007; 21: 1119-1127.
21. Rifkin BS, Perazella MA. Tenofovir-associated nephrotoxicity: Fanconi's syndrome and renal failure. Am J Med 2004; 117: 282-284.
22. Mauss S, Berger F, Schmutz G. Antiretroviral therapy with tenofovir is associated with mild renal dysfunction. AIDS 2005; 19: 93-95.
23. James CW, Steinhaus MC, Szabo S et al. Tenofovir-related nephrotoxicity: case report and review of the literature. Pharmacotherapy 2004; 3: 415-418.
24. Murphy MS, O'Hearn M, Chou S. Fatal lactic acidosis and acute renal failure after addition of tenofovir to an antiretroviral regimen containing didanosine. Clin Infect Dis2003; 36: 1082-1085.
25. Izzedine H, Isnard-Bagnis C, Hulot JS et al. Renal safety of tenofovir in HIV treatment-experienced patients. AIDS 2004; 18: 1074-1076.
26. Peyriere H, Reynes J, Rouanet I et al. Renal tubular dysfunction associated with tenofovir therapy: Report of 7 cases. J Acquir Immune Defic Syndr 2004; 35: 269-273.
27. Antoniou T, Raboud J, Chirhin S et al. Incidence of and risk factors for tenofovir-induced nephrotoxicity: A retrospective cohort study. HIV Med 2005; 4: 284-290.
28. Barrios A, Garcia-Benayas T, Gonzalez-Lahoz J et al. Tenofovir-related nephrotoxicity in HIV-infected patients. AIDS 2004; 18: 960-963.
29. Zimmerman AE, Pizzoferrato T, Bedford J et al. Tenofovir-associated acute and chronic kidney disease: A case of multiple drug interactions. Clin Infect Dis 2006; 42: 283-290.
30. Fux C, Christen A, Zgraggen S et al. Effect of tenofovir on renal glomerular and tubular function. AIDS 2007; 21: 1483-1485.
31. Stevens LA, Coresh J, Greene T et al. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006; 354: 2473-2483.
32. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (Suppl. 1): S1-S266.
33. Rigalleau V, Lasseur C, Perlemoine C et al. Estimation of glomerular filtration rate in diabetic subjects: Cockcroft formula or modification of diet in renal disease study equation? Diabetes Care 2005; 2: 838-843.
34. MacAulay J, Thompson K, Kiberd BA et al. Serum creatinine in patients with advanced liver disease is of limited value for identification of moderate renal dysfunction: Are the equations for estimating renal function better? Can J Gastroenterol 2006; 20: 521-526.
35. Kuan Y, Hossain M, Surman J et al. GR prediction using the MDRD and Cockcroft Gault equations in patients with end-stage renal disease. Nephrol Dial Transplant 2005; 20: 2394-2401.
36. Marx GM, Blake GM, Galani E et al. Evaluation of the Cockcroft-Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients. Ann Oncol 2004; 15: 291-295.
37. Levey AS, Coresh J, Balk E et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147.
38. Levey AS. Measurement of renal function in chronic kidney disease. Kidney Int 1990; 38: 17-84.
39. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: New insights into old concepts. Clin Chem 1992; 38: 1933-1953.
40. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
41. Panel on Antiretroviral Guidelines for Adult and Adolescents. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Washington, DC: Department of Health and Human Services. January 28, 2008. Available online: http://aidsinfo.nih.gov/contentfiles/ AdultandAdolescentGL.pdf
42. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 1999; 130: 461-470.
43. Levey AS, Greene T, Kusek J et al. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11: 155A.
44. Stevens LA, Levey AS. eds. Frequently Asked Questions About GFR Estimates. New York: National Kidney Foundation, 2004.
45. Verhave JC, Fesler P, Ribstein J et al. Estimation of renal function in subjects with normal serum creatinine levels: Influence of age and body mass index. Am J Kidney Dis 2005; 46: 233-241.
46. Rule AD, Larson TS, Bergstralh EJ et al. Using serum creatinine to estimate glomerular filtration rate: Accuracy in good health and in chronic kidney disease. Ann Intern Med 2004; 141: 929-937.
47. Lin J, Knight EL, Hogan ML et al. A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease. J Am Soc Nephrol 2003; 14: 2573-2580.
48. Bostom AG, Kronenberg F, Ritz E. Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. J Am Soc Nephrol 2002; 13: 2140-2144.
49. Poggio ED, Wang X, Greene T et al. Performance of modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in Health and chronic kidney disease. J Am Soc Nephrol 2005; 16: 459-466.
50. Vervoort G, Willems HL, Wetzes JF. Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation. Nephrol Dial Transplant 2002; 17: 1909-1913.
51. Froissart M, Rossert J, Jacquot C et al. Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol 2005; 16: 763-773.
52. Myers GL, Miller WG, Coresh J et al. Recommendations for improving serum creatinine measurement: A report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 2006; 52: 5-18.